Autobio Diagnostics Co., Ltd. (SHA:603658)
China · Delayed Price · Currency is CNY 31.14
-0.99 (-3.08%)
Sep 11, 2026, 3:00 PM CST
Autobio Diagnostics Market Cap
Autobio Diagnostics has a market cap or net worth of 17.79 billion as of September 11, 2026. Its market cap has decreased by -24.62% in one year.
Market Cap
17.79B
Enterprise Value
14.74B
Revenue
4.22B
Ranking
n/a
PE Ratio
18.07
Stock Price
31.14
ChartMarket Cap Chart
Since September 1, 2016, Autobio Diagnostics's market cap has increased from 8.82B to 17.79B, an increase of 101.75%. That is a compound annual growth rate of 7.25%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 17.79B | -12.08% |
| Dec 31, 2025 | 20.24B | -18.93% |
| Dec 31, 2024 | 24.97B | -24.62% |
| Dec 29, 2023 | 33.12B | -8.65% |
| Dec 30, 2022 | 36.26B | 12.33% |
| Dec 31, 2021 | 32.28B | -50.70% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Yuyue Medical Equipment & Supply | 25.25B |
| MGI Tech | 22.37B |
| Lepu Medical Technology (Beijing) | 20.61B |
| Double Medical Technology | 15.65B |
| Shandong Weigao Blood Purification Products | 12.86B |
| Insight Lifetech | 12.36B |
| MeHow Innovative | 12.11B |
| Jafron Biomedical | 11.59B |